首页 正文

Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma

{{output}}
Introduction: Adrenocortical carcinoma (ACC) is a rare cancer with suboptimal response to chemotherapy. The role of immunotherapy in ACC management is evolving. M... ...